Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study

Wang Qiang,Tian Shui,Tang Hao,Liu Xiaoxue,Yan Rui,Hua Lingling,Shi Jiabo,Chen Yu,Zhu Rongxin,Lu Qing,Yao Zhijian

DOI: https://doi.org/10.1016/j.jad.2019.04.046

IF: 6.533

2019-01-01

Journal of Affective Disorders

Abstract:Background: Major depressive disorder (MDD) is associated with a heavy disease burden due to the difficulty in diagnosing the disorder and the uncertainty of treatment outcomes. Previous studies have demonstrated the value of functional connectivity (FC) between the dorsolateral prefrontal cortex (DLPFC) and the subgenual anterior cingulate cortex (sgACC) in the identification of MDD and the prediction of antidepressant efficacy. In the present study, we aimed to investigate whether FC is helpful in discriminating patients from healthy controls and in predicting treatment outcome. Methods: Seventy-six medication-free patients with MDD and 28 healthy controls were enrolled in the study. Magnetoencephalography (MEG) and the Hamilton Rating Score for Depression (HRSD-17) were administered at baseline. Then, the HRSD-17 was assessed weekly until each patient met the remission criteria, defined as a total HRSD-17 score <= 7. Time-dependent Cox regression analysis was used to evaluate the association between FC and the incidence of remission. Results: Healthy controls and MDD patients had opposite FC patterns; this may be helpful for identifying MDD (AUC = 0.8, p < 0.001, sensitivity 85.7%, specificity 67.9%). Alpha connectivity between the DLPFC and sgACC (HR 1.858, 95%CI 1.013-3.408, p = 0.045) was found to be an independent factor associated with better final antidepressant outcome. Limitations: This study was conducted in a small sample of subjects. Further, the direction of regulation between the DLPFC and sgACC was not considered. Conclusions: FC may help identify depression and may be related to the severity of depressive symptoms and predict the efficacy of antidepressant treatment.